Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk’s injected Saxenda (liraglutide). The compound, ...

More than half of people prescribed weight-loss drugs Saxenda and Wegovy over the past decade ended their treatment too early to realize meaningful health benefits, according to a study by a major U.S ...

PARSIPPANY, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the FDA approval and U.S.

These findings further confirm the safety profile of Saxenda and are comparable to the safety data seen at 56 weeks. Novo Nordisk announced that the Food and Drug Administration (FDA) has approved a ...

GLP-1 diabetes and weight loss medications like Ozempic, Wegovy and Saxenda are being investigated by the European Union for causing suicidal thoughts, and while drug manufacturer Novo Nordisk denies ...

As the demand for affordable healthcare options grows, the pharmaceutical industry is increasingly focused on developing generic drugs to expand access and reduce costs. This trend is driving major ...

The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report. The findings, published Tuesday in the New England Journal of Medicine and ...

Saxenda® (liraglutide) injection 3 mg becomes the first FDA-approved therapy to treat obesity in adolescents in more than a decade PLAINSBORO, N.J., Dec. 4, 2020 /PRNewswire/ -- Novo Nordisk today ...

Share on Pinterest Experts say people should expect to be on weight loss medications for a long period of time. NurPhoto/Getty Images Researchers report that more than half of people on weight loss ...